Inari Medical Inc (NARI)’s financial ratios: A comprehensive overview

In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.

In other words, the price has increased by $0.00 from its previous closing price. On the day, 3.87 million shares were traded. NARI stock price reached its highest trading level at $79.47 during the session, while it also had its lowest trading level at $79.29.

Ratios:

We take a closer look at NARI’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 41.66 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 865.91. For the most recent quarter (mrq), Quick Ratio is recorded 1.40 and its Current Ratio is at 1.77. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.07.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on December 17, 2024, initiated with a Outperform rating and assigned the stock a target price of $75.

On September 18, 2024, Stifel started tracking the stock assigning a Hold rating and target price of $50.

On September 03, 2024, Leerink Partners started tracking the stock assigning a Market Perform rating and target price of $47.Leerink Partners initiated its Market Perform rating on September 03, 2024, with a $47 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 06 ’25 when Hoffman William sold 200,000 shares for $60.47 per share. The transaction valued at 12,093,174 led to the insider holds 238,987 shares of the business.

WILLIAM HOFFMAN bought 200,000 shares of NARI for $9,954,000 on Jan 06 ’25. On Dec 20 ’24, another insider, Hykes Andrew, who serves as the President and CEO of the company, sold 3,000 shares for $55.29 each. As a result, the insider received 165,870 and left with 439,310 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NARI now has a Market Capitalization of 4649949696 and an Enterprise Value of 4569592320. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.09 while its Price-to-Book (P/B) ratio in mrq is 10.67. Its current Enterprise Value per Revenue stands at 7.954 whereas that against EBITDA is -174.866.

Stock Price History:

The Beta on a monthly basis for NARI is 0.96, which has changed by 0.3811097 over the last 52 weeks, in comparison to a change of 0.22677135 over the same period for the S&P500. Over the past 52 weeks, NARI has reached a high of $79.69, while it has fallen to a 52-week low of $36.73. The 50-Day Moving Average of the stock is 40.86%, while the 200-Day Moving Average is calculated to be 63.95%.

Shares Statistics:

According to the various share statistics, NARI traded on average about 2.03M shares per day over the past 3-months and 7706740 shares per day over the past 10 days. A total of 58.44M shares are outstanding, with a floating share count of 50.51M. Insiders hold about 13.74% of the company’s shares, while institutions hold 89.38% stake in the company. Shares short for NARI as of 1735603200 were 3838977 with a Short Ratio of 1.89, compared to 1732838400 on 2916586. Therefore, it implies a Short% of Shares Outstanding of 3838977 and a Short% of Float of 8.290000000000001.

Most Popular